J. B. Chemicals & Pharmaceuticals Limited
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. J. B. Chemicals & Pharmaceuticals Limited's past years’ income statements indicate that its last revenue has increased compared to the previous period by 42% to $34,476,710,000. The net income raised on $5,526,278,000 and profit margin reached 16%. Total operating expenses were $14,792,542,000.
Profit Margin
| 2010 | 7.40B | 1.18B | 16.03% |
|---|---|---|---|
| 2011 | 8.41B | 1.39B | 16.55% |
| 2012 | 8.01B | 6.77B | 84.54% |
| 2015 | 10.48B | 1.00B | 9.57% |
| 2016 | 11.68B | 1.61B | 13.86% |
| 2018 | 13.85B | 1.38B | 9.99% |
| 2019 | 16.10B | 1.93B | 12.01% |
| 2021 | 20.05B | 4.47B | 22.33% |
| 2022 | 24.24B | 3.85B | 15.9% |
| 2024 | 34.47B | 5.52B | 16.03% |
JBCHEPHARM.NS Income Statement (2010 – 2023)
| 2023 | 2021 | 2020 | 2018 | 2017 | 2015 | 2014 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 34.47B | 24.24B | 20.05B | 16.10B | 13.85B | 11.68B | 10.48B | 8.01B | 8.41B | 7.40B |
Cost of revenue | 21.21B | 8.63B | 7.17B | 6.21B | 5.61B | 5.19B | 4.75B | 3.59B | 2.73B | -32.19M |
Gross profit | 13.25B | 15.60B | 12.88B | 9.88B | 8.23B | 6.48B | 5.73B | 4.41B | 5.67B | 7.44B |
Operating exp. | ||||||||||
Research and development | 356.71M | 291.07M | 235.34M | 238.84M | 322.38M | 221.70M | 134.81M | 0 | 0 | 0 |
Selling and marketing | 3.81B | 2.58B | 1.77B | 1.71B | 1.41B | 1.10B | 1.18B | 980.47M | 0 | 0 |
Total operating expenses | 14.79B | 10.86B | 8.00B | 7.30B | 6.61B | 5.00B | 4.57B | 3.26B | 4.21B | 5.96B |
Operating income | 7.54B | 4.73B | 4.89B | 2.58B | 1.67B | 2.08B | 1.45B | 1.15B | 1.45B | 1.48B |
Other income (expenses), net | -26.54M | 310.05M | 1.07B | 287.37M | 334.34M | 0 | 0 | 7.27B | -195.52M | 0 |
Income before tax | 7.51B | 5.04B | 5.96B | 2.86B | 1.93B | 2.08B | 1.45B | 8.43B | 1.65B | 1.48B |
Income tax expense | 1.98B | 1.18B | 1.48B | 930.22M | 552.31M | 469.09M | 451.43M | 1.65B | 260.16M | 293.20M |
Net income | 5.52B | 3.85B | 4.47B | 1.93B | 1.38B | 1.61B | 1.00B | 6.77B | 1.39B | 1.18B |
Earnings per share | ||||||||||
Basic EPS | 35.66 | 24.93 | 28.98 | 23.54 | 16.48 | 19.16 | 11.84 | 80.11 | 16.5 | 14.08 |
Diluted EPS | 34.85 | 24.91 | 28.98 | 23.54 | 16.48 | 19.16 | 11.84 | 80.11 | 16.46 | 14.08 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |